Universal Cells Inc. logo

Universal Cells Inc.

Universal Cells uses recombinant adeno-associated virus (rAAV)-mediated gene editing to efficiently edit chromosomal genes without the use of genotoxic nucleases. rAAV vectors are effective and safe, and have been used in numerous clinical trials. We have licensed a stem cell-tropic rAAV vector serotype for engineering human pluripotent stem cells. Our technology allows us to produce customized stem cells that contain deletions, insertions, or point mutations at any genomic position.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.universalcells.com
Founded2013
Disease Focus
Development Stage
STOCK CODENon Listed
Address
3005 1st Ave Seattle, WA 98121
Seattle
United States
Email
Contact Number
+1 425 246 5454

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/universal-cell” connections=”true” suffix=””]